Mindforce Game Lab

Mindforce Game Lab is a Swedish digital-health game developer founded in 2017. Based in the Gothenburg area, the studio brings together game development and behavioral health to create mobile experiences that support people managing mental health conditions. Its work centers on proprietary games and digital therapeutic products, with interactive characters designed to accompany users as they build consistent everyday routines.

The studio’s flagship production, Fig, is also known as Fig: The Game for Depression and Fig: A Playtient Journey. Available for iOS and Android, it combines a story-driven game with support for people experiencing depression. The product is CE-marked as a Class I medical device in Europe and is designed as an adjunct to treatment for people with major depressive disorder or bipolar depression who face residual symptoms or difficulties maintaining treatment routines.

Games built around everyday habits

Players meet an alien companion named Fig and explore an evolving magical world. Maintaining daily wellness routines advances the story and unlocks new gameplay episodes, connecting activities outside the game with progress inside it. The experience incorporates principles of cognitive behavioral therapy, psychoeducation and behavioral activation.

The routines addressed include medication adherence, sleep, nutrition and physical activity. Mindforce calls its users “playtients,” reflecting its approach to combining patient support with the sustained engagement of video games. Its products use narrative and companionship to make repeated health-related activities part of an ongoing interactive experience.

Development and clinical collaboration

Mindforce develops its own intellectual property rather than primarily supplying third-party game production services. Its capabilities span serious game development, digital therapeutic app engineering and behavioral health gamification. The studio also works with academic researchers to evaluate its products, including collaborations with Linköping University and Stockholm University. FigRx is a clinical-trial and prescription-track iteration of the platform.

The company began in Skellefteå’s innovation and games ecosystem before relocating its core development operations to the Gothenburg area in late 2020. Its development history connects northern Sweden’s games community with the life-science environment around AstraZeneca BioVentureHub.